MX2010004262A - Formulaciones topicas de glicopirrolato. - Google Patents

Formulaciones topicas de glicopirrolato.

Info

Publication number
MX2010004262A
MX2010004262A MX2010004262A MX2010004262A MX2010004262A MX 2010004262 A MX2010004262 A MX 2010004262A MX 2010004262 A MX2010004262 A MX 2010004262A MX 2010004262 A MX2010004262 A MX 2010004262A MX 2010004262 A MX2010004262 A MX 2010004262A
Authority
MX
Mexico
Prior art keywords
formulations
further comprise
glycopyrrolate formulations
topical glycopyrrolate
polymer
Prior art date
Application number
MX2010004262A
Other languages
English (en)
Inventor
Michael Johnston
Robert James Houlden
Original Assignee
Stiefel Res Australia Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40567708&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2010004262(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Stiefel Res Australia Pty Ltd filed Critical Stiefel Res Australia Pty Ltd
Publication of MX2010004262A publication Critical patent/MX2010004262A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0208—Tissues; Wipes; Patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Formulaciones tópicas empacadas de manera individual que comprenden de aproximadamente 0.25 a aproximadamente 6% en peso/peso de glicopirrolato para el tratamiento de la hiperhidrosis, en donde la toallita está contenida dentro de una bolsita resistente a las fugas; las formulaciones pueden comprender además etanol, un agente amortiguador y agua, además, las formulaciones pueden comprender un sistema polimérico que comprende un polímero hidrofóbico en combinación con un polímero hidrofílico.
MX2010004262A 2007-10-18 2008-10-17 Formulaciones topicas de glicopirrolato. MX2010004262A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US96088707P 2007-10-18 2007-10-18
PCT/US2008/011907 WO2009051818A1 (en) 2007-10-18 2008-10-17 Topical glycopyrrolate formulations

Publications (1)

Publication Number Publication Date
MX2010004262A true MX2010004262A (es) 2010-05-14

Family

ID=40567708

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010004262A MX2010004262A (es) 2007-10-18 2008-10-17 Formulaciones topicas de glicopirrolato.

Country Status (7)

Country Link
US (6) US8618160B2 (es)
EP (2) EP3415127B1 (es)
AU (2) AU2008314628B2 (es)
CA (1) CA2702830C (es)
ES (2) ES2969237T3 (es)
MX (1) MX2010004262A (es)
WO (1) WO2009051818A1 (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2097074A4 (en) * 2006-12-04 2013-05-01 Glaxosmithkline Llc TOPICAL PHARMACEUTICAL COMPOSITION
CA2702830C (en) 2007-10-18 2017-02-28 Stiefel Research Australia Pty Ltd Topical glycopyrrolate formulations
EP2515855B3 (en) 2009-12-23 2023-05-03 Chiesi Farmaceutici S.p.A. Combination therapy for COPD
EP2515856B1 (en) * 2009-12-23 2014-04-02 Chiesi Farmaceutici S.p.A. Aerosol Formulation for COPD
SG181870A1 (en) 2009-12-23 2012-07-30 Chiesi Farma Spa Aerosol formulation for copd
CA2896939C (en) 2013-01-03 2022-07-12 Hidros Therapeutics International Ab Treatment of hyperhidrosis
US9006462B2 (en) 2013-02-28 2015-04-14 Dermira, Inc. Glycopyrrolate salts
CA2902795C (en) * 2013-02-28 2021-06-15 Dermira, Inc. Glycopyrrolate salts
US8558008B2 (en) 2013-02-28 2013-10-15 Dermira, Inc. Crystalline glycopyrrolate tosylate
DK2968267T3 (en) 2013-03-15 2018-06-25 Bodor Laboratories Inc SOFT ANTICHOLINERGE ESTERS FOR TREATMENT OF HYPERHIDROSE
SG11201600045UA (en) * 2013-07-30 2016-02-26 Glaxosmithkline Ip Dev Ltd Topical compositions for treatment of excessive sweating and methods of use thereof
US20150259283A1 (en) * 2014-03-13 2015-09-17 Brickell Biotech, Inc. Formulation for soft anticholinergic analogs
WO2015138700A1 (en) 2014-03-13 2015-09-17 Bodor Laboratories, Inc. Use of selected anticholinergic zwitterions
US9926270B2 (en) 2014-08-20 2018-03-27 Dermira, Inc. Process for production of glycopyrronium tosylate
WO2016033313A1 (en) * 2014-08-27 2016-03-03 Dermira, Inc. Hyperhidrosis treatment
US20220233500A1 (en) * 2014-08-29 2022-07-28 Journey Medical Corporation Glycopyrrolate salts
MX2017005190A (es) 2014-10-24 2017-07-27 Unilever Nv Dispensador para una crema, un gel o una composicion solida blanda.
US10194730B2 (en) 2014-10-24 2019-02-05 Conopco, Inc. Method of controlling perspiration
AU2016236521B2 (en) 2015-03-20 2019-03-07 Unilever Global Ip Limited Antiperspirant composition
AU2016297601B2 (en) 2015-07-21 2021-08-19 Bodor Laboratories, Inc. Formulation for soft anticholinergic analogs
PT109445B (pt) 2016-06-08 2018-11-06 Hovione Farm Sa Co-cristais farmacêuticos cristalinos de brometo de glicopirrónio com lactose
TWI767507B (zh) 2016-07-21 2022-06-11 美商波德實驗股份有限公司 軟性抗膽鹼類似物之製劑
EP3494106B1 (en) 2016-08-02 2022-07-20 Journey Medical Corporation Processes for making, and methods of using, glycopyrronium compounds
EP3860589A4 (en) 2018-11-06 2022-06-08 Harman Finochem Limited PROCESS FOR THE PREPARATION OF GLYCOPYRROLATE ATTOSYLATE
AU2020349599A1 (en) 2019-09-20 2022-03-31 Unilever Global Ip Limited Antiperspirant compositions
WO2021113260A1 (en) 2019-12-02 2021-06-10 Dermira, Inc. Diester containing compounds for treating hyperhidrosis
WO2022258385A2 (en) 2021-06-07 2022-12-15 Unilever Ip Holdings B.V. Compositions and methods for controlling sweat production

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2118566A (en) 1935-08-29 1938-05-24 Miles Gilbert De Wayne Buffered cosmetic
US2956062A (en) 1959-02-26 1960-10-11 Robins Co Inc A H Esters of amino alcohols
US3767786A (en) 1961-04-20 1973-10-23 Procter & Gamble Inhibiting perspiration with scopolamine esters
IL22666A (en) 1964-01-06 1968-10-24 Robins Co Inc A H Compositions for inhibiting perspiration containing an 1,1-dialkyl-3-hydroxy-pyrrolidinium ester of an alpha-phenyl-alpha-cycloalkyl-clycolic or acetic acid
US3312709A (en) 1964-06-29 1967-04-04 Procter & Gamble Para-(lower)alkoxybenzoylscopolamine
DE1670048C3 (de) 1966-01-26 1980-09-04 C.H. Boehringer Sohn, 6507 Ingelheim Neue Norscopolaminderivate
US4355020A (en) * 1977-11-12 1982-10-19 Bert Kuy Thixotropic aluminum hydroxide chloride and medical and other applications thereof
CA1120874A (en) * 1978-04-14 1982-03-30 Ralph G. Amberg Composite container
US4415551A (en) * 1982-01-29 1983-11-15 The Gillette Company Bioerodible deodorant
US4824676A (en) 1984-10-11 1989-04-25 Schering Corporation Physiological means of enhancing transdermal delivery of drugs
US4891227A (en) 1988-02-02 1990-01-02 Richardson-Vicks Inc. Medicated cleansing pads
GB8811408D0 (en) * 1988-05-13 1988-06-15 Unilever Plc Cosmetic composition
US4883792A (en) * 1989-01-17 1989-11-28 Peter Timmins Steroid cream formulation
WO1993025186A1 (en) * 1992-06-16 1993-12-23 Klein Marvin E Composition for the treatment of skin
US5403588A (en) * 1993-11-23 1995-04-04 Santa Ana, Jr.; Cesareo T. Disposable body deodorant pad and deodorant preparation therefor
US5525347A (en) 1995-01-31 1996-06-11 Medical University Of South Carolina Composition and methods for treating performance anxiety
US5648083A (en) * 1995-02-10 1997-07-15 The Procter & Gamble Company Personal care compositions and wipe products containing the compositions
US6214792B1 (en) 1996-04-12 2001-04-10 David Lew Simon Method for treating acute and severe diarrhea
US5919760A (en) 1996-04-12 1999-07-06 Intensive Narcotic Detoxification Centers Of America, Llc Method for treating acute and severe diarrhea
EP0920313A1 (en) 1996-07-01 1999-06-09 Sepracor, Inc. Methods and compositions for treating urinary incontinence using enantiomerically enriched (s,s)-glycopyrrolate
WO1998000016A1 (en) 1996-07-01 1998-01-08 Sepracor, Inc. Methods and compositions for treating urinary incontinence using enantiomerically enriched (r,r)-glycopyrrolate
AUPO379596A0 (en) 1996-11-22 1996-12-19 Soltec Research Pty Ltd Percutaneous delivery system
ES2118053B1 (es) 1997-02-27 1999-03-01 Julia Capmany Font M Luisa Producto para la limpieza de la piel y faneras.
US5962505A (en) 1998-08-31 1999-10-05 Bobrove; Arthur M. Method for treating hot flashes in humans
US5976499A (en) 1998-09-04 1999-11-02 Johns Hopkins University Macroscopic sweat test for cystic fibrosis
US6433003B1 (en) 1999-04-23 2002-08-13 Arthur M. Bobrove Method for treating hyperhidrosis in mammals
US6446795B1 (en) 2000-07-31 2002-09-10 The Gillette Company Towelette packaging
ATE324335T1 (de) * 2001-12-22 2006-05-15 Procter & Gamble Verpackung für zusammenpressbare produkte sowie verfahren zur herstellung der verpackung
CA2384922C (en) 2002-05-03 2008-09-02 Purepharm Inc. Topical glycopyrrolate product for the reduction of sweating
US8252316B2 (en) * 2002-05-03 2012-08-28 Purepharm Inc. Method of topically applying glycopyrrolate solution using absorbent pad to reduce sweating
WO2006069998A2 (de) * 2004-12-27 2006-07-06 Beiersdorf Ag Glycopyrrolat in kosmetischen zubereitungen
PL1863476T3 (pl) 2005-03-16 2016-07-29 Meda Pharma Gmbh & Co Kg Skojarzenie środków antycholinergicznych i antagonistów receptora leukotrienowego do leczenia chorób układu oddechowego
CA2702830C (en) 2007-10-18 2017-02-28 Stiefel Research Australia Pty Ltd Topical glycopyrrolate formulations
US8558008B2 (en) 2013-02-28 2013-10-15 Dermira, Inc. Crystalline glycopyrrolate tosylate
CA2902795C (en) 2013-02-28 2021-06-15 Dermira, Inc. Glycopyrrolate salts
US9006462B2 (en) 2013-02-28 2015-04-14 Dermira, Inc. Glycopyrrolate salts

Also Published As

Publication number Publication date
US20210290496A1 (en) 2021-09-23
US20180311116A1 (en) 2018-11-01
CA2702830C (en) 2017-02-28
US11071694B2 (en) 2021-07-27
EP3415127A1 (en) 2018-12-19
AU2008314628B2 (en) 2014-03-06
AU2014203072A1 (en) 2014-07-03
AU2014203072B2 (en) 2016-05-26
ES2671874T3 (es) 2018-06-11
US20230270631A1 (en) 2023-08-31
AU2014203072C1 (en) 2019-04-04
EP2200550A1 (en) 2010-06-30
US8618160B2 (en) 2013-12-31
ES2969237T3 (es) 2024-05-17
US20180008517A1 (en) 2018-01-11
EP2200550A4 (en) 2016-01-27
US10052267B2 (en) 2018-08-21
US20140151255A1 (en) 2014-06-05
US20100276329A1 (en) 2010-11-04
US9744105B2 (en) 2017-08-29
EP2200550B1 (en) 2018-04-18
WO2009051818A1 (en) 2009-04-23
EP3415127B1 (en) 2023-12-20
CA2702830A1 (en) 2009-04-23
AU2008314628A1 (en) 2009-04-23

Similar Documents

Publication Publication Date Title
MX2010004262A (es) Formulaciones topicas de glicopirrolato.
MX2010009839A (es) Composiciones de saneamiento de la piel antimicrobianas de alcohol incluyendo espesadores compatibles cationicos.
MX2010003258A (es) Utilizacion de un nuevo agente natural en composiciones cosmeticas.
CA2713555C (en) Topical compositions and methods for whitening skin
MX348797B (es) Microorganismos probioticos como agentes activos para mejorar el brillo de la tez de la piel.
WO2006085907A3 (en) Sanitizing composition and method of preparation
WO2007077561A3 (en) Compositions and methods for enhancing in-vivo uptake of pharmaceutical agents
MX2012006629A (es) Microorganismos probioticos como agentes activos contra cambios en microrelieve de la piel.
AU2007211617A1 (en) Hydrogel
WO2007128939A3 (fr) Association d'un agent ou dispositif tenseur et d'un compose saccharidique
MX2010002247A (es) Uso de una combinacion de hesperidina y de un microorganismo para influir en la funcion de barrera de la piel.
EP2070509A3 (en) The use of Myrica gale oil
WO2008010991A3 (en) Methods and compositions for the treatment of cancer
ES2356883A1 (es) Composicion para el tratamiento del dolor y/o la inflamacion.
HK1142536A1 (en) Gel useful for the delivery of cosmetic active ingredients
WO2010062581A3 (en) A botanical composition for enhanced skin repair and uses thereof
WO2006121522A3 (en) Implantable sensors and pumps, anti-scarring agents, and therapeutic compositions
MY182983A (en) A skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof
MX348531B (es) Dispositivo de lata de aerosol para suministro tópico dual.
MX2009002224A (es) Composicion a base de xantoxilina y su utilizacion en cosmetica.
HK1112721A1 (en) Tissue disruption treatment and composition for use thereof
MX2009012710A (es) Nuevo humectante y uso del mismo.
GB0606015D0 (en) therapeutic agents
AU321830S (en) Bottle
WO2009106555A3 (fr) Gel de sucralfate sterilise

Legal Events

Date Code Title Description
GB Transfer or rights

Owner name: ROSE U LLC

FG Grant or registration